tailieunhanh - Báo cáo hóa học: " Biotechnology entrepreneurship - where no research has gone before"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành hóa học dành cho các bạn yêu hóa học tham khảo đề tài: Biotechnology entrepreneurship - where no research has gone before | Salgaller and Marincola Journal of Translational Medicine 2010 8 102 http content 8 1 102 JOURNAL OF TRANSLATIONAL MEDICINE EDITORIAL Open Access Biotechnology entrepreneurship - where no research has gone before Michael L Salgaller 1 Francesco M Marincola2 Editorial Many researchers have a scientific interest in taking their translational studies from bench to bedside. They want to take their ideas and see how far they can go towards bringing medical solutions to as many patients as possible. However it can be frustrating when the clinical development of their work is beyond the scope and capabilities of their university or hospital. Even for those institutions with research beds studies are usually limited to small pilot studies. Even for those institutions with the necessary financial support the manufacturing regulatory and legal essentials are not in place to evolve such studies to larger later-stage human trials. This is nothing new. What is new is the rising tide of researchers turning to the for-profit world. Either directly - by starting their own companies or indirectly - by working with existing pharmaceutical and biotechnology companies researchers are moving more and more technologies towards the marketplace. Biotechnology Entrepreneurship From Science to Solutions provides a real-world introduction to starting and growing life science companies as well as useful material for medical researchers interested in getting their technologies to as many patients as possible. Increasingly universities and medical research centers are making technology transfer and development - such as filing patents and establishing formal industry relationships - a factor in tenure and promotion evaluation the new millennia version of publish or perish. The out-licensing and commercialization of life science technologies are becoming valued parts of the academic career ladder. For example North Carolina State University tenure and promotion .